AzPA Southwestern Clinical Seminar. JW Marriott Starr Pass Blvd., Tucson, AZ

Transcription

1 AzPA Southwestern Clinical Seminar JW Marriott 3800 Starr Pass Blvd., Tucson, AZ Time Program CE 8:00-9:30am Emerging Infectious Disease Outbreaks in Arizona, the U.S., and the World Lydia Plante, MSPH, Office of Infectious Disease Service, Arizona Department of Health Services Goals: The educational goal is to provide an overview of emerging infectious disease outbreaks of importance. These outbreaks will include Ebola, chikungunya, dengue, and a brief update on Enterovirus D68. It will include updates on the creation of vaccines, as well as the current epidemiology and clinical trends in the ongoing outbreaks. Learning objectives for Pharms: 1. Identify ongoing infectious disease outbreaks, and their locations. 2. Understand why these outbreaks matter to Arizona (despite having no locally acquired cases). 3. Identify which diseases (of the ones involved in ongoing outbreak) have vaccines, or where they are in terms of research and development. 4. Understand important epidemiological and clinical take away messages for the ongoing outbreaks of concern. 5. Understand ongoing infectious disease outbreaks, and their locations. 6. Describe why these outbreaks matter to Arizona (despite having no locally acquired cases). 7. Be familiar with which diseases (of the ones involved in ongoing outbreak) have vaccines, or where they are in terms of research and development. 8. Understand the epidemiological impact of the ongoing outbreaks of concern. ACPE UAN#: L04-P; # L04-T 9:30-10:30am 2015 Immunization Update Kelly Ridgway, RPh., FAzPA, of AzPA, CEO Goals: Educate pharmacists and technicians on updated ACIP Guidelines and new vaccines. Learning Objectives for pharmacists: 2. Identify indications and contraindications for the following vaccines: pneumococcal, meningococcal, and HPV. Learning Objectives for technicians: 2. Learn about the uses of vaccines to prevent pneumococcal, meningococcal, and HPV disease. 3. Identify newly approved vaccines and ACIP approved indications for these vaccines. ACPE UAN#: L04-P; L04-T

2 9:30-10:30am New Drug Update-Quality or Quantity Part 1 Robert Lipsy, Pharm.D., BCPS, FASHP, University of Arizona College of Pharmacy Medication Management Center, Tucson, AZ Goals: This program has been developed to educate pharmacists and technicians on the new developments in pharmacotherapy. Learning Objectives: 1. Compare and contrast the glucose-lowering efficacy and adverse event profile of dulaglutide to other 2. GLP-1 agonists. 3. Compare and contrast the glucose-lowering efficacy and adverse event profile of empagliflozin to other oral hypoglycemics and other SGLT-2 inhibitors. Learning objectives for Techs: 1. Identify the use and dosage for of dulaglutide and GLP-1 agonist. 2. Identify the use and doseage for of empaglifozin and SGLT-2 inbitors. 3. Identify the use of suvorexant and how it differs from other hyponotics. 9:30-10:30am 10:45-11:45am ACPE UAN#: L04-P and ACPE UAN# L04-T JNC 8: Clear answers at last? Nicole Scovis, Pharm.D., BCPS, BCACP Goals: This program has been developed to educate pharmacists on management of hypertension. Learning Objectives: 1. Identify goals and appropriate therapy for patients based on recommendations from 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8). 2. Describe the evidence level of recommendations from JNC8. Recognize differences in hypertension recommendations between JNC8 and guidelines by other organizations. ACPE UAN#: L04-P 2015 Immunization Update Kelly Ridgway, RPh., FAzPA, of AzPA, CEO Goals: Educate pharmacists and technicians on updated ACIP Guidelines and new vaccines. Learning Objectives for pharmacists: 2. Identify indications and contraindications for the following vaccines: pneumococcal, meningococcal, and HPV. Learning Objectives for technicians: 2. Learn about the uses of vaccines to prevent pneumococcal, meningococcal, and HPV disease. 3. Identify newly approved vaccines and ACIP approved indications for these vaccines. ACPE UAN#: L04-P; L04-T

3 10:45-11:45am New Drug Update-Quality or Quantity Part II Robert Lipsy, Pharm.D., BCPS, FASHP, University of Arizona College of Pharmacy Medication Management Center, Tucson, AZ Goals: This program has been developed to educate pharmacists and technicians on the new developments in pharmacotherapy. 1. Describe the relative benefit of dual action anti-emetics compared to a drug with a single mechanism of action. 2. Compare and contrast the spectrums of antibacterial coverage of tedizolid and ortavancin. 3. Describe the common hematologic toxicities of belinostat. 1. Identify different classes of anti-emetics. 2. Identify the use and differences between tedizolid and ortavancin. 3. Understand the common hematologic toxicities of belinostat. 10:45-11:45am 1:00-2:30pm ACPE UAN#: L04-P and ACPE UAN# L04-T JNC 8: Clear answers at last? Nicole Scovis, Pharm.D., BCPS, BCACP Goals: This program has been developed to educate pharmacists on management of hypertension. Learning Objectives: 1. Identify goals and appropriate therapy for patients based on recommendations from 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8). 2. Describe the evidence level of recommendations from JNC8. Recognize differences in hypertension recommendations between JNC8 and guidelines by other organizations. ACPE UAN#: L04-P Describing the Business Case for Pharmacist Integration in Pay-for-Value Healthcare Financing Brian Isetts, Ph.D., BCPS, FAPhA, University of Minnesota 1. Understand the service level expectations of pharmacists functioning in highperforming interprofessional healthcare teams. 2. Describe the relationship of outcomes studies in pharmacy to clinical and economic measures of success in reimbursement reform. 3. State the business case for pharmacist integration in redesigned healthcare delivery and financing. 4. Convince payers and stakeholders that they can exceed their financial goals with pharmacists contributions to accountable medication use. 1. Understand the service level expectations of pharmacists functioning in highperforming interprofessional healthcare teams. 2. Describe the relationship of outcomes studies in pharmacy to clinical and economic measures of success in reimbursement reform. 3. State the business case for pharmacist integration in redesigned healthcare delivery and financing.

4 2:30-3:30pm 2:30-3:30pm 2:30-3:30pm UAN#: L04-P; L04-T START and STOPP and Beers... Oh My! Navigating the World of Geriatrics Jessica DiLeo, Pharm.D. University of Arizona College of Pharmacy, and Katherine Murphy, Pharm.D., United States Air Force Goals: This program has been developed to assist pharmacists in identifying and monitoring inappropriate medication use among geriatric patients with an emphasis on minimizing adverse events and optimizing patient outcomes. 1. Identify pharmacodynamic and pharmacokinetic parameters that may influence treatment options among geriatric patients. 2. Identify common references for optimizing medication use in the elderly. 3. Conduct a patient chart review and identify factors which may influence and/or contribute to potentially inappropriate treatment options among geriatric patients. 4. Recognize and review pertinent counseling points for medications on the Beers List and STOPP/START criteria. 1. Identify common classes of medications that may increase fall risk. 2. Identify factors which may influence or contribute to potential adverse drug effects in the geriatric patients. 3. Understand physiological differences between geriatrics and younger adults. ACPE UAN#: L04-P; L04-P Breaking the triad of the unholy trinity : the pharmacist role in substance misuse and the treatment of pain Lisa Goldstone, Pharm.D., of University of Arizona College of Pharmacy Medication Management Center, Tucson and Dawn Cylwik, Pharm.D., PGY1 Pharmacy Resident, El Rio Health Care, Tucson Goals: This program has been developed to educate pharmacists and/or pharmacy technicians on current trends with substance misuse and best practices in the treatment of pain. 1. Describe current trends in substance misuse 2. Identify patients at risk for misusing substances 3. Recognize safe and appropriate pain treatment plans 1. Describe current trends in substance misuse 2. Identify patients at risk for misusing substances 3. Recognize medications that are commonly abused ACPE UAN#: L04-P; L04-T Impact of Pharmacists on the Management of HIV/AIDS Caryn Queiruga, Pharm.D. AAHIVP, Clinical Pharmacist at Avella Specialty Pharmacy, Tucson, Arizona Goals: This program has been developed to educate pharmacists on strategies that can be used to improve HIV/AIDS in the community. Learning Objectives Pharmacists: 1. Identify unique needs of the HIV/AIDS community in order to provide effective HIV/AIDS care. 2. Describe barriers to care and identify methods to overcome them.

5 3. Describe the role of pharmacists in the management of HIV/AIDS. Learning Objectives for Technicians 1. Identify unique needs of the HIV/AIDS community in order to provide effective HIV/AIDS care. 2. Describe barriers to care and identify methods to overcome them. 3. Describe the role of pharmacists in the management of HIV/AIDS 3:45-5:15pm SUN., FEB. 22 8:00-9:30am ACPE UAN# L02-P; L02-T Managing Encounters of the Southwest- David E. Nix, Pharm.D., BCPS-AQ(ID), Goals: This session will provide pharmacists with the latest information on the diagnosis and treatment of this condition which can help patients achieve earlier diagnosis and receive appropriate therapy. May be edited 1. Describe the impact of Valley Fever on Arizona. 2. Recognize when to consider Valley Fever in a patient. 3. Discuss treatment controversies. 4. Describe a vision of 10 years. May be edited 1. Describe the impact of Valley Fever on Arizona. 2. Recognize when to consider Valley Fever in a patient. 3. Discuss treatment controversies. 4. Describe a vision of 10 years. UAN# L04-P; L04-T Introduction to Travel Health: A Pharmacist's Perspective Andrew Gaspar, RPh, BCACP, of Safeway, Patient Care Services Manager, Phoenix, AZ and Vanthida Huang, Pharm.D., FCCP of Midwestern University College of Pharmacy, Glendale, AZ Goals: The focus of the discussion will on informing patients regarding informing and educating pharmacists and pharmacy technicians regarding giving best practice for travel meds for traveling patients, legal requirements, and proper documentation. 1. Understand the different disease states and other consideration of travel health 2. Understand the pharmacist s role in travel health considerations 3. Understand the regulations governing travel health in Arizona Learning objectives for Technicians: 1. Understand the different disease states and other consideration of travel health 2. Understand the pharmacist s role in travel health considerations 3. Understand the regulations governing travel health in Arizona ACPE UAN# L04-P / ACPE UAN# L04-T

6 10:15-11:15am 10:15-11:15am 11:30am- 1:00pm Considerations for the management of Hepatitis C in Patients with HIV Coinfection Marcella Honkonen, PharmD, BCPS of University of Arizona College of Pharmacy Goals: This program has been developed to educate pharmacists on the current guidelines for the management of patients with Hepatitis C Virus infection. 1. Define the drug therapy options available for the treatment of Hepatitis C Virus. 2. Identify pertinent drug-drug interactions regarding the management of HCV/HIV coinfection. 3. Describe the monitoring needed when managing treatment regimens for patients with HCV/HIV co-infection. Learning objectives for Technicians: 1. Identify the drug used to treat Hepatitis C. 2. Recognize common monitoring done for patients with HCV/HIV co-infection. 3. Understand the impact that drug-drug interactions can have on HCV/HIV co-infection. UAN# L01-P; L01-T Future Trends in Specialty Pharmacy-Pipeline, Prior Auths and Patient Care Marcella Honkonen, PharmD, BCPS of University of Arizona College of Pharmacy Goals: This program has been developed to educate pharmacists on the current guidelines for the management of patients with Hepatitis C Virus infection. 1. Discuss the future trends anticipated to impact how specialty pharmaceuticals are delivered to patients. 2. Discuss management strategies for escalating specialty drug expenses (payor and payee). 3. Discuss methods of advancing the value of medication therapy management. Learning objectives for Technicians: 1. Recognize the future trends anticipated to impact how specialty pharmaceuticals are delivered to patients. 2. Discuss management strategies for escalating specialty drug expenses (payor and payee). 3. Understand the value of medication therapy management. UAN# L04-P; L04-T Pharmacy Law Update 2015 Roger Morris, RPh., JD, of Quarles and Brady, LLP Goals: This program has been developed to educate pharmacists and/or pharmacy technicians on current developments in federal and state pharmacy laws 1. Understand recent legislative, regulatory, and judicial actions that directly affect the delivery of pharmacy services by pharmacists and technicians in all practice settings. 2. Examine the legal trends in pharmacy compliance and legal risk when delivering pharmacy services. 3. Examine how the legal trends will affect business relationships in your area of practice. Learning objectives for technicians:

7 1. Understand recent legislative, regulatory, and judicial actions that directly affect the delivery of pharmacy services by pharmacists and technicians in all practice settings. 2. Examine the legal trends in pharmacy compliance and legal risk when delivering pharmacy services. 3. Examine how the legal trends will affect business relationships in your area of practice. ACPE UAN# L03-P; L03-T